1093.HK - CSPC Pharmaceutical Group Limited

HKSE - HKSE Delayed Price. Currency in HKD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue15,462,52912,369,04111,393,72610,955,077
Cost of Revenue6,116,5616,060,2326,172,8486,767,724
Gross Profit9,345,9686,308,8095,220,8784,187,353
Operating Expenses
Research Development----
Selling General and Administrative5,056,6483,341,8542,801,8392,339,729
Non Recurring----
Others812,878309,784245,932176,658
Total Operating Expenses11,986,0879,711,8709,220,6199,284,111
Operating Income or Loss3,476,4422,657,1712,173,1071,670,966
Income from Continuing Operations
Total Other Income/Expenses Net-11,153-21,839-61,058-49,482
Earnings Before Interest and Taxes3,476,4422,657,1712,173,1071,670,966
Interest Expense-26,631-41,711-56,335-54,358
Income Before Tax3,465,2892,635,3322,112,0491,621,484
Income Tax Expense685,245522,107432,423337,153
Minority Interest85,02383,69674,55272,374
Net Income From Continuing Ops2,780,0442,113,2251,679,6261,284,331
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income2,770,5222,100,8481,665,2711,268,446
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares2,770,5222,100,8481,665,2711,268,446